Toru Yoshizawa

Title: Toru Yoshizawa: Innovator in Antibody Formulations

Introduction

Toru Yoshizawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of antibody formulations. With a total of six patents to his name, Yoshizawa's work focuses on innovative solutions for stabilizing and administering antibodies.

Latest Patents

Yoshizawa's latest patents include formulations containing anti-IL-31RA antibodies. One of his notable inventions is a lyophilized formulation that includes an IL-31 antagonist as an active ingredient, along with arginine and/or a salt thereof, and sucrose and/or trehalose. Additionally, he has developed solution formulations that also contain an IL-31 antagonist and arginine. His patents further explore methods for stabilizing antibodies, suppressing aggregation, and reducing charge heterogeneity in antibody formulations.

Career Highlights

Throughout his career, Yoshizawa has worked with esteemed organizations such as Chugai Pharmaceutical Co., Ltd. and Saitama Medical University. His experience in these institutions has allowed him to refine his expertise in antibody research and formulation.

Collaborations

Yoshizawa has collaborated with notable colleagues, including Daisuke Kameoka and Megumi Numata. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Toru Yoshizawa's innovative work in antibody formulations has positioned him as a key figure in biochemistry. His contributions continue to impact the field, showcasing the importance of research and development in medical science.